OHSU

IRB #

IRB00006256

Title

I-SPY 2 TRIAL: Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging and Molecular Analysis 2

Principal Investigator

Kathleen Kemmer

Study Purpose

This study is being done to better understand how women respond to standard chemotherapy alone or combined with an investigational drug to treat breast cancer.

Medical Condition(s)

Invasive cancer of the female breast

Eligibility Criteria

1. Female aged 18 years or older
2. Histologically confirmed breast cancer
3. No prior treatment for breast cancer
4. Willing and able to undergo biopsy of primary breast tumor

Age Range

18 - 100

Healthy Volunteers Needed

No

Duration of Participation

5 years

Minors Included

No

Contact

Deirdre Nauman, RN
503-494-3078

Sponsor

FNIH

Recruitment End

12/30/2016

Compensation Provided

No


Go Back